Navigation Links
Strativa Pharmaceuticals Provides Product Pipeline Update
Date:4/20/2009

contingencies, many of which are beyond the control of the Company, which could cause actual results and outcomes to differ materially from those expressed herein. Risk factors that might affect such forward-looking statements include those set forth in Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2007, in Item 1A of the Company's subsequent Quarterly Reports on Form 10-Q, in other of the Company's filings with the SEC from time to time, including Current Reports on Form 8-K, and on general industry and economic conditions. Any forward-looking statements included in this news release are made as of the date hereof only, based on information available to the Company as of the date hereof, and, subject to any applicable law to the contrary, the Company assumes no obligation to update any forward-looking statements.


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals, a Division of Par Pharmaceutical
2. Strativa Pharmaceuticals Acquires Commercialization Rights to Thin Film Formulation of Ondansetron From MonoSol Rx
3. Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical
4. MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip
5. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
8. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
10. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... Santa Rosa was recently recognized, for the fourth ... Healthcare. In the KLAS “2015 Midterm Performance Review: Software & Services”, Santa Rosa achieved ... from Modern Healthcare and KLAS are directly related to our company culture.” said Richard ...
(Date:8/27/2015)... ... August 28, 2015 , ... ... out of foster care through “The Language of Flowers,” has joined the Youth ... work, particularly the organization’s YVLifeSet program, was piqued by her passion for helping ...
(Date:8/27/2015)... ... 2015 , ... According to an article published August 21st on ... the success of a patient who is attempting to lose weight. Specifically, the trial ... over that period, and compared those results with how helpful each patient felt their ...
(Date:8/27/2015)... ... August 27, 2015 , ... Workflow ... quantitative PCR (qPCR) in the last decade. New features such as ... costs. On the flipside, where do lab managers, technicians, and researchers find handy ...
(Date:8/27/2015)... , ... August 27, 2015 , ... Thriveology Founders, Dr. ... featured speakers at The Amazing Aging Expo in Denver, Colorado on Saturday, August 29, ... are consistently featured in media outlets as health authorities, and will present a two ...
Breaking Medicine News(10 mins):Health News:Santa Rosa Consulting Recognized by Modern Healthcare as One of the Top 100 Best Places to Work and from KLAS Research with the Highest Rating for Go-Live Support 2Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 2Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 3Health News:Article on Physician Influence on Weight Loss Highlights the Importance of a Doctor Who Cares, says Dr. Feiz & Associates 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2
... SIMI VALLEY, Calif., Oct. 10 Dr. ... maintained that techniques,exist to naturally reduce dependence on ... study published in the Journal of,Human Hypertension has ... chiropractic adjustments to correct,misalignment of the atlas vertebrae ...
... Movement, Takes on New ... Role at Dept. of State, ... Brinker, founder of Susan G. Komen for,the Cure, the world,s largest ... U.S. Department of State. Mrs. Laura Bush,was in attendance for the ...
... visit a worksite in your,community, contact Tim ... tkral@oregonrehabilitation.org , 503-585-3337. For,current photos, contact ... The Oregon Rehabilitation Association (ORA), http://www.oregonrehabilitation.org, ... with disabilities this October with National Disability,Employment ...
... Inc (OTC,Bulletin Board: NNTN) announced today that it,s ... record unaudited sales of $4,439,000 (CDN) and $601,000 ... July, August, and September 2007. Tim,Connolly, CEO of ... record,results for our first full quarter for InterACTIVE ...
... Succeed Antoine, CINCINNATI, Oct. 10, 2007 ... that Richard L. Antoine, global human resources,officer, will ... 39 years of,service. (Photo: http://www.newscom.com/cgi-bin/prnh/20071010/CLW078-a ... http://www.newscom.com/cgi-bin/prnh/20071010/CLW078-b ) In ...
... Yum! Brands Launches Global Campaign to Raise Awareness of ... WASHINGTON, Oct. 10 Friends of the World,Food ... World Hunger,Relief Week, a global consumer campaign that will ... Relief Week is spearheaded,by Yum! Brands, the world,s largest ...
Cached Medicine News:Health News:Lower Blood Pressure Without Drugs 2Health News:Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol 2Health News:Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol 3Health News:Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol 4Health News:Revision: October is National Disability Employment Awareness Month 2Health News:Natural Nutrition Subsidiary Reports Record Third Quarter Revenue and EBITDA 2Health News:Richard L. Antoine to Retire as P&G's Global HR Officer 2Health News:Friends of WFP Welcomes 'World Hunger Relief Week' 2
(Date:8/27/2015)... 27, 2015  The Academy of Managed Care ... Administration,s (FDA,s) draft guidance and proposed rule that ... to bear a nonproprietary name with an FDA-designated ... a decision from the FDA on the naming ... stakeholders urging the agency to use the same ...
(Date:8/27/2015)... , Aug. 27, 2015  A recent ... KSSTA Knee Journal, compared the Arthrosurface HemiCAP® Wave ... design, versus an "onlay" design implant for isolated ... improvements in function and pain scores, none of ... of osteoarthritis (OA). However, 53% of the patients ...
(Date:8/27/2015)... CUPERTINO, Calif. , Aug. 27, 2015 ... management is scheduled to present at three upcoming healthcare ... , President and CEO, will present at the Rodman ... 10:00 a.m. Eastern time. The conference is being held ... York City . A live audio webcast of ...
Breaking Medicine Technology:AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3DURECT to Participate in Upcoming Healthcare Conferences 2
... SAN DIEGO, April 7, 2008 A ... shows that a proprietary blend,extracted from canola, Dermytol(TM), ... Dermytol(TM), a proprietary compound,developed by KGK Synergize Inc., ... protect skin cells from damage that may lead ...
... Research Meeting, DURHAM, N.C., April 7, 2008 ... dedicated to,treating diseases resulting from the failure of ... a Phase I clinical,safety study of a novel ... dry mouth associated with primary Sjogren,s syndrome. The,preliminary ...
Cached Medicine Technology:New Study Shows Proprietary Canola Extract, Dermytol(TM), Produces Pronounced Decrease in Malignant Melanoma Tumor Volume 2Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment 2Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment 3
... Used for temporary internal ... to the bladder. The filiform ... placement. Supplied sterile in peel-open ... CAUTION: Periodic evaluation is advised; ...
The horizontal needle box stores loaded needles according to the implant dosimetry plan. The ergonomic and lightweight design reduces time in the operating room....
The vertical needle holder conveniently positions 20 needles vertically in numbered positions for easy loading....
The Brachytherapy C-arm table is a versatile, adjustable table featuring hand and foot controls, removable sections, an X-ray film tray and grid, accessory rails and standard rail mount knee crutches...
Medicine Products: